期刊文献+

窖蛋白-1和RhoE在肝癌癌变过程中表达及其临床意义 被引量:5

Clinical significance of Caveolin-1 and RhoE expression in the carcinogenesis of primary liver carcinoma
原文传递
导出
摘要 目的 探讨窖蛋白-1(Caveolin-1)和RhoE在原发性肝癌(PLC)癌变过程中表达及其临床意义.方法 采用免疫组织化学法检测20例正常肝组织、32例肝硬化组织和68例PLC组织中Caveolin-1和RhoE表达水平.结果 Caveolin-1在正常肝组织、肝硬化组织和PLC组织中的表达率分别为85.00% (17/20)、56.25% (18/32)和27.94%(19/68),两两比较差异有统计学意义(P<0.05),Caveolin-1表达水平与PLC癌细胞分化程度、血管浸润明显相关(P<0.05);RhoE蛋白在正常肝组织、肝硬化组织和PLC组织中的表达率分别为95.00%(19/20)、71.88%(23/32)和50.00%(34/68),两两比较差异有统计学意义(P <0.01);RhoE表达水平与PLC肿瘤大小、血管浸润、TNM分期明显相关(P<0.05).结论 Caveolin-1和RhoE在肝癌病变发展过程中起重要作用. Objective To investigate the expression of Caveolin-1 and RhoE in primary liver carcinoma (PLC),and their relation to the clinicopathological features and the prognostic value.Methods Immunohistochemical method was used to assess the expression of Caveolin-1 and RhoE in 20 normal liver tissues,32 cirrhosis tissues and 68 PLC tissues.Results The expression rate of Caveolin-1 in normal liver tissues,cirrhosis tissues and PLC tissues was 85.00% (17/20),56.25% (18/32) and 27.94% (19/68) with significant difference (P < 0.05).The expression levels of Caveolin-1 were related to histology grade and blood vessel invasion of PLC (P < 0.05).The expression rate of RhoE in normal liver tissues,cirrhosis tissues and PLC tissues was 95.00% (19/20),71.88% (23/32) and 50.00% (34/68) with significant difference (P < 0.05).There was a close relation between the expression of RhoE and histology grade,blood vessel invasion and TNM stage (P < 0.05).Conclusion The expression of Caveolin-1 and RhoE may play an important role in the carcinogenesis of liver carcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第8期1805-1807,共3页 Chinese Journal of Experimental Surgery
关键词 原发性肝癌 窖蛋白-1 RHOE Primary liver carcinoma Caveolin-1 RhoE
  • 相关文献

参考文献6

二级参考文献16

  • 1徐涛,陈孝平,李丹,卢凌,黄志勇,张万广.CD147在兔VX2模型肿瘤组织的表达及意义[J].中华实验外科杂志,2007,24(1):37-39. 被引量:9
  • 2张惠忠,魏益平,华平,杨艳旗,熊利华,陈炬,刘金耿,吴澄,曹永科.非小细胞肺癌淋巴结转移和预后与CD133和CD147表达的关系[J].中华实验外科杂志,2007,24(7):873-874. 被引量:11
  • 3Liang QL, Chen GQ, Li ZY, et al. Function and histopathology of a cell adhesion molecule TSLC1 in cancer. Cancer Invest, 2011,29: 107- 112. 被引量:1
  • 4Liang QL, Wang BR, Li ZY, et 81. Construction of eukaryotic expres- sion vector of TSLC1 gene. Arch Med Sci,2011,7 :579-585. 被引量:1
  • 5Liang QL, Wang BR, Li ZY, et al. Effect of TSLC1 gene on growth and apoptosis in human esophageal carcinoma Ecal09 cells. Arch Med Sci ,2012,8:987-992. 被引量:1
  • 6Liang QL,Li ZY,Zhou Y. Construction of a recombinant eukaryotic expression vector containing PHD3 gene and its expression in HepG2 cells[J].{H}Journal of Experimental and Clinical Cancer Research,2012.64. 被引量:1
  • 7Liu QL,Liang QL,Li ZY. Function and expression of prolyl hydroxylase 3 in cancers[J].Arch Med Sci,2013,(4):589-593. 被引量:1
  • 8Zhao H,Yang J,Fan T. RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway[J].{H}TUMOUR BIOLOGY,2012,(5):1363-1374. 被引量:1
  • 9Grise F,Sena S,Bidaud-Meynard A. Rnd3/RhoE is down-regulated in hepatocellular carcinoma and controls cellular invasion[J].{H}HEPATOLOGY,2012,(6):1766-1775. 被引量:1
  • 10马力,刘月平,张祥宏,邢凌霄,王俊灵,耿翠芝.反义RNA抑制Ezrin表达对乳腺癌细胞侵袭能力的影响[J].中华实验外科杂志,2009,26(4):425-427. 被引量:3

共引文献22

同被引文献33

  • 1顾栋桦,唐峰,王震,李华,陈琦,朱虹光.caveolin-1对喉鳞状细胞癌生物学特性的影响[J].中华肿瘤杂志,2007,29(5):329-333. 被引量:7
  • 2Sohn J, Brick RM, Tuan RS. From embryonicdevelopment to human diseases: Thefimctional role of caveolae/caveolin[J]. BirthDefects Res C Embryo Today, 2016,108(l):45-64. 被引量:1
  • 3Lamaze C, Torrino S. Caveolae and cancer:A new mechanical perspective[J]. BiomedJ, 2015,38(5):367-379. 被引量:1
  • 4Zhang K, Yang G, Wu W, et al. DecreasedExpression o f Caveolin-1 and E-CadherinCorrelates with the Clinicopathologic Featuresof Gastric Cancer and the EMT Process[J]. Recent Pat Anticancer Drug EMscov,2016, ll(2):236-244. 被引量:1
  • 5Quann K, Gonzales DM, Mercier I, et al.Caveolin-1 is a negative regulator of tumorgrowth in glioblastoma and modulateschemosensitivity to temozolomide[J]. CellCycle, 2013,12(10): 1510-1520. 被引量:1
  • 6Juan HM, Santiago RV, David HM, et al.Caveolin-1 is down-regulated in alveolarrhabdomyosarcomas and negatively regulatestumor growth[J]. Oncotarget, 2014,5(20):9744-9755. 被引量:1
  • 7Jung AC, Ray AM, Ramolu L, et al. Caveolin-1-negative head and neck squamouscell carcinoma primary tumors display increasedepithelial to mesenchymal transitionand prometastatic properties[J]. Oncotarget,2015,6(39):418841901. 被引量:1
  • 8Tahir SA, Park S, Thompson TC. Caveolin-1regulates VEGF-stimulated angiogenic activilies in prostate cancer and endothelial cells[J]. Cancer Biol Ther, 2009,8(23): 2286-2296. 被引量:1
  • 9Kim EK, Choi EJ. Compromised MAPKsignaling in human diseases: an update[J].Arch Toxicol, 2015, 89(6):867-882. 被引量:1
  • 10Sohn J, Brick RM, Tuan RS. From embryonicdevelopment to human diseases: Thefimctional role of caveolae/caveolin[J]. BirthDefects Res C Embryo Today, 2016,108(l):45-64. 被引量:1

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部